Rebound psychoses following the discontinuation of a high potency neuroleptic.
Increased familiarity with the effects of psychotropic medications has led to modifications in both prescribing habits and length of treatment. The case of a 34 year old woman is presented, in whom the return of psychotic symptoms following the discontinuation of neuroleptic medications is attributed to a rebound phenomena as opposed to a relapse of an underlying chronic illness. The author cites parallel situations previously described in the medical literature and outlines a conceptual framework for the understanding of this phenomenon.
Kahne
G J
GJ
D000328:Adult; D004305:Dose-Response Relationship, Drug; D005260:Female; D006220:Haloperidol / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D011605:Psychoses, Substance-Induced / Q000209:etiology*; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
D006220:Haloperidol